Nuwellis Inc (NUWE) Stock Price, Quote & News - Mboum

Company Profile

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and...

Industry: Medical Devices

Sector: Healthcare

Phone: 952 345 4200

Website: www.nuwellis.com

Address:

12988 Valley View Road, Eden Prairie, United States

done84 Jul. 28 at 2:59 PM

$NUWE worthless junk. Under $1 soon. 🖕🖕

0 · Reply

bazooka007 Jul. 28 at 2:19 PM

$NUWE no volume, mofos playing games as usual. Keep cool.

0 · Reply

Russell007x Jul. 28 at 1:55 PM

$NUWE short this to 2 dollars

0 · Reply

IndicatorGator Jul. 27 at 7:52 AM

$DNUT, $RSLS, $MBIO, $PROK, $NUWE

0 · Reply

IndicatorGator Jul. 27 at 7:49 AM

SWING TRADING: Two Examples of Swing Trades info you get while learning how to trade in the Day Trade for Life Community. $DNUT $3.50 to $5.97 (70%) See image $RSLS 2.38 to $4.01 (68%) See image -Add in the PROFITABLE Day Trade Alerts, Watchlist, Education, and Premium Scanner Suite and you get the best value of any Community. -See posts on profile for Daily and Monthly results. -See PINNED POST on profile to Join Us. -FOLLOW and SUBSCRIBE $MBIO, $NUWE, $PROK

1 · Reply

MythicalDragon Jul. 26 at 1:25 AM

$NUWE Patents are good

0 · Reply

done84 Jul. 25 at 7:46 PM

$NUWE under $1 soon + another R/S and endless dilution. Scam company. F*ck you CHFS or NUWE or whatever you POS! 🖕🖕🖕

0 · Reply

bazooka007 Jul. 25 at 6:34 PM

$NUWE hardly any volume. Mofos playing games .

0 · Reply

Russell007x Jul. 25 at 5:19 PM

$NUWE going to 2 dollars

0 · Reply

Russell007x Jul. 25 at 4:35 PM

$NUWE short this MF to 2 dollars

0 · Reply

Latest News on NUWE

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Jul 23, 2025, 8:45 AM EDT - 5 days ago

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Jul 23, 2025, 8:15 AM EDT - 5 days ago

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

Jul 22, 2025, 8:15 AM EDT - 6 days ago

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

Jul 17, 2025, 7:35 AM EDT - 11 days ago

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation

Jul 15, 2025, 4:05 PM EDT - 12 days ago

Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation

Nuwellis Appoints John Erb as Chief Executive Officer

Jul 2, 2025, 8:15 AM EDT - 26 days ago

Nuwellis Appoints John Erb as Chief Executive Officer

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

Jun 10, 2025, 4:15 PM EDT - 6 weeks ago

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

Jun 9, 2025, 9:15 AM EDT - 7 weeks ago

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

Nuwellis, Inc. (NUWE) Q1 2025 Earnings Call Transcript

May 13, 2025, 10:50 AM EDT - 2 months ago

Nuwellis, Inc. (NUWE) Q1 2025 Earnings Call Transcript

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

May 13, 2025, 7:00 AM EDT - 2 months ago

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

May 12, 2025, 7:00 AM EDT - 2 months ago

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

May 8, 2025, 7:00 AM EDT - 2 months ago

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

Apr 24, 2025, 7:00 AM EDT - 3 months ago

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

Apr 22, 2025, 4:05 PM EDT - 3 months ago

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

Nuwellis, Inc. (NUWE) Q4 2024 Earnings Call Transcript

Mar 11, 2025, 12:23 PM EDT - 4 months ago

Nuwellis, Inc. (NUWE) Q4 2024 Earnings Call Transcript

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

Mar 11, 2025, 8:00 AM EDT - 4 months ago

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO

Feb 24, 2025, 4:05 PM EST - 5 months ago

Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO

JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis

Feb 20, 2025, 8:00 AM EST - 5 months ago

JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

Feb 18, 2025, 4:15 PM EST - 5 months ago

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

Nuwellis, Inc. (NUWE) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 11:02 AM EST - 9 months ago

Nuwellis, Inc. (NUWE) Q3 2024 Earnings Call Transcript

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

Nov 11, 2024, 8:00 AM EST - 9 months ago

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

Nov 5, 2024, 9:28 AM EST - 9 months ago

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Nov 4, 2024, 8:30 AM EST - 9 months ago

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Nuwellis Announces Preliminary Results for Third Quarter of 2024

Nov 1, 2024, 4:15 PM EDT - 9 months ago

Nuwellis Announces Preliminary Results for Third Quarter of 2024

Nuwellis Welcomes University of Iowa Health Care Stead Family Children's Hospital as Newest Pediatric Customer

Oct 31, 2024, 8:00 AM EDT - 9 months ago

Nuwellis Welcomes University of Iowa Health Care Stead Family Children's Hospital as Newest Pediatric Customer

Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024

Oct 23, 2024, 4:15 PM EDT - 9 months ago

Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024

Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference

Sep 25, 2024, 4:15 PM EDT - 10 months ago

Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference

Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Aug 23, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Nuwellis, Inc. (NUWE) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 12:39 PM EDT - 1 year ago

Nuwellis, Inc. (NUWE) Q2 2024 Earnings Call Transcript

Nuwellis, Inc. Announces Second Quarter 2024 Financial Results

Aug 13, 2024, 8:00 AM EDT - 1 year ago

Nuwellis, Inc. Announces Second Quarter 2024 Financial Results

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical's QUELIMMUNE™ Therapy at Cincinnati Children's

Jul 26, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical's QUELIMMUNE™ Therapy at Cincinnati Children's

Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules

Jul 24, 2024, 8:02 AM EDT - 1 year ago

Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules

Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024

Jul 23, 2024, 4:10 PM EDT - 1 year ago

Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children's

Jul 17, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children's

Nuwellis Announces Reverse Stock Split

Jun 26, 2024, 8:45 AM EDT - 1 year ago

Nuwellis Announces Reverse Stock Split

Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™

Jun 25, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™

DaVita, Nuwellis Extend Pilot Collaboration for Aquadex

Jun 11, 2024, 12:46 PM EDT - 1 year ago

DaVita, Nuwellis Extend Pilot Collaboration for Aquadex

Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase

Jun 6, 2024, 9:00 AM EDT - 1 year ago

Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase

Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in Florida

May 14, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in Florida

Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration Therapy

May 9, 2024, 9:00 AM EDT - 1 year ago

Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration Therapy

Nuwellis, Inc. (NUWE) Q1 2024 Earnings Call Transcript

May 7, 2024, 10:29 AM EDT - 1 year ago

Nuwellis, Inc. (NUWE) Q1 2024 Earnings Call Transcript

Nuwellis, Inc. Announces First Quarter 2024 Financial Results

May 7, 2024, 8:00 AM EDT - 1 year ago

Nuwellis, Inc. Announces First Quarter 2024 Financial Results

Nuwellis Announces Closing of $2.7 Million Public Offering

Apr 30, 2024, 6:09 PM EDT - 1 year ago

Nuwellis Announces Closing of $2.7 Million Public Offering

Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024

Apr 30, 2024, 4:41 PM EDT - 1 year ago

Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024

Nuwellis Announces Pricing of $2.7 Million Public Offering

Apr 26, 2024, 9:17 AM EDT - 1 year ago

Nuwellis Announces Pricing of $2.7 Million Public Offering

Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference

Mar 7, 2024, 9:08 AM EST - 1 year ago

Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference

Nuwellis, Inc. (NUWE) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 12:11 PM EST - 1 year ago

Nuwellis, Inc. (NUWE) Q4 2023 Earnings Call Transcript

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results

Mar 5, 2024, 8:00 AM EST - 1 year ago

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

Feb 27, 2024, 9:00 AM EST - 1 year ago

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

Nuwellis' Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™

Feb 22, 2024, 7:58 AM EST - 1 year ago

Nuwellis' Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™

done84 Jul. 28 at 2:59 PM

$NUWE worthless junk. Under $1 soon. 🖕🖕

0 · Reply

bazooka007 Jul. 28 at 2:19 PM

$NUWE no volume, mofos playing games as usual. Keep cool.

0 · Reply

Russell007x Jul. 28 at 1:55 PM

$NUWE short this to 2 dollars

0 · Reply

IndicatorGator Jul. 27 at 7:52 AM

$DNUT, $RSLS, $MBIO, $PROK, $NUWE

0 · Reply

IndicatorGator Jul. 27 at 7:49 AM

SWING TRADING: Two Examples of Swing Trades info you get while learning how to trade in the Day Trade for Life Community. $DNUT $3.50 to $5.97 (70%) See image $RSLS 2.38 to $4.01 (68%) See image -Add in the PROFITABLE Day Trade Alerts, Watchlist, Education, and Premium Scanner Suite and you get the best value of any Community. -See posts on profile for Daily and Monthly results. -See PINNED POST on profile to Join Us. -FOLLOW and SUBSCRIBE $MBIO, $NUWE, $PROK

1 · Reply

MythicalDragon Jul. 26 at 1:25 AM

$NUWE Patents are good

0 · Reply

done84 Jul. 25 at 7:46 PM

$NUWE under $1 soon + another R/S and endless dilution. Scam company. F*ck you CHFS or NUWE or whatever you POS! 🖕🖕🖕

0 · Reply

bazooka007 Jul. 25 at 6:34 PM

$NUWE hardly any volume. Mofos playing games .

0 · Reply

Russell007x Jul. 25 at 5:19 PM

$NUWE going to 2 dollars

0 · Reply

Russell007x Jul. 25 at 4:35 PM

$NUWE short this MF to 2 dollars

0 · Reply

done84 Jul. 25 at 2:12 PM

$NUWE overvalued. 🖕🖕🖕

0 · Reply

CAPITALWHISPERER Jul. 25 at 1:40 PM

$ABP $LHAI $NUWE

0 · Reply

CAPITALWHISPERER Jul. 25 at 12:42 PM

$ABP $1 next leg. $13 last run. $1.7B merger with Celtrion coming. omg new $LHAI and $NUWE

0 · Reply

CAPITALWHISPERER Jul. 24 at 8:45 PM

$OCTO $4 next leg. nano float 2m. BITCOIN. boom boom like $NUWE and $CYCC

0 · Reply

CAPITALWHISPERER Jul. 24 at 8:06 PM

$OPI $NUWE $CYCC

0 · Reply

CAPITALWHISPERER Jul. 24 at 7:04 PM

$OPI $NUWE $ASST

0 · Reply

CAPITALWHISPERER Jul. 24 at 5:29 PM

$OPI $NUWE $CYCC

0 · Reply

CAPITALWHISPERER Jul. 24 at 5:22 PM

$OPI $1 coming. giving dividends. $15.80 book value. $3.5B assets. new $NUWE and $ASST

1 · Reply

CAPITALWHISPERER Jul. 24 at 5:15 PM

$OPI $15.80 book value. omg $3.5B assets. new $NUWE and $CYCC

1 · Reply

done84 Jul. 24 at 3:59 PM

$NUWE short this junk to ATL! 🖕🖕

0 · Reply

CAPITALWHISPERER Jul. 24 at 11:36 AM

$GSIW $NUWE $CYCC

0 · Reply

CAPITALWHISPERER Jul. 24 at 11:21 AM

$GSIW 800% today like $NUWE and $CYCC

0 · Reply